Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Via Turconi 23 CP 1652, 6850, Mendrisio, Switzerland.
Department of Obstetrics and Gynecology, EOC-Civico Hospital, Università della Svizzera Italiana, Lugano, Switzerland.
Int Urogynecol J. 2020 Apr;31(4):739-744. doi: 10.1007/s00192-019-04096-4. Epub 2019 Aug 28.
The tension-free vaginal tape ABBREVO (TVT-A) is a new surgical procedure for the treatment of female stress urinary incontinence (SUI). However, data reporting medium- and long-term outcomes are lacking. The aim of the study was to assess the efficacy and safety of TVT-A in patients with at least a 3-year follow-up.
All consecutive women who complained of pure SUI symptoms with urodynamically proven SUI undergoing a TVT-A procedure were prospectively enrolled. Data regarding subjective outcomes (International Consultation on Incontinence Questionnaire-Short Form, Patient Global Impression of Improvement and patient satisfaction scores), objective cure (stress test) rates and adverse events were collected during follow-up. Univariate analysis was performed to investigate outcomes.
A total of 41 women underwent TVT-A implantation. At 3-year follow-up, 40 women (97.5%) were available for the evaluation. We did not find any significant change in surgical outcomes during this time. At 3 years after surgery, 36 of 40 (90%) patients were subjectively cured (p for trend 0.18) and 37 out of 40 (92.5%) patients were objectively cured (p for trend 0.22). The univariate analysis did not find any risk factor statistically associated with the recurrence of SUI. A significant trend of de novo overactive bladder (OAB) occurrence was registered at the 3-year follow-up (p for trend = 0.03). No serious late complications or groin-thigh pain were reported.
TVT-A implantation is a highly effective option for the treatment of women with pure SUI.
无张力阴道吊带 ABBREVO(TVT-A)是一种治疗女性压力性尿失禁(SUI)的新手术方法。然而,缺乏报告中短期结果的数据。本研究的目的是评估 TVT-A 在至少 3 年随访的患者中的疗效和安全性。
所有连续抱怨有纯 SUI 症状且尿动力学证实有 SUI 的女性患者均行 TVT-A 手术,前瞻性入组。在随访期间收集有关主观结局(国际尿失禁咨询委员会问卷-简短表、患者总体改善印象和患者满意度评分)、客观治愈率(压力测试)和不良事件的数据。进行单变量分析以调查结局。
共有 41 名女性接受了 TVT-A 植入术。在 3 年随访时,有 40 名女性(97.5%)可进行评估。在此期间,我们未发现手术结局有任何显著变化。手术后 3 年,40 名患者中有 36 名(90%)主观治愈(p 趋势=0.18),40 名患者中有 37 名(92.5%)客观治愈(p 趋势=0.22)。单变量分析未发现任何与 SUI 复发有统计学关联的风险因素。在 3 年随访时,新发膀胱过度活动症(OAB)的发生呈显著趋势(p 趋势=0.03)。未报告严重的迟发性并发症或腹股沟-大腿疼痛。
TVT-A 植入术是治疗单纯性 SUI 女性的一种非常有效的选择。